Analyst Reco. Laekna, Inc.

Equities

Market Closed - Hong Kong S.E. Other stock markets 09:08:32 29/05/2024 BST			5-day change	1st Jan Change
6.8 ^HKD	-3.41%		-5.69%	-65.83%

05-23	US FDA Gives Green Light to Laekna's Phase 3 Trial for Prostate Cancer Drug; Shares Rise 8%	MT
05-23	Laekna, Inc. Announces Approval by the U.S. Food and Drug Administrationfor the Phase III Clinical Trial Protocol Of LAE002 (Afuresertib) Plus LAE001 for the Treatment Ofprostate Cancer	CI

No results for this search